DONGYIN GUAN to Humans
This is a "connection" page, showing publications DONGYIN GUAN has written about Humans.
Connection Strength
0.120
-
Genetics-nutrition interactions control diurnal enhancer-promoter dynamics and liver lipid metabolism. Cell Metab. 2025 Oct 07; 37(10):1961-1979.e7.
Score: 0.026
-
Human genetic variation determines 24-hour rhythmic gene expression and disease risk. Nat Commun. 2025 May 08; 16(1):4270.
Score: 0.025
-
Circadian Regulation of Gene Expression and Metabolism in the Liver. Semin Liver Dis. 2022 05; 42(2):113-121.
Score: 0.020
-
Interconnections between circadian clocks and metabolism. J Clin Invest. 2021 08 02; 131(15).
Score: 0.019
-
The potential of 4-Methylumbelliferone to be repurposed for treating liver fibrosis. Biomed Pharmacother. 2025 Sep; 190:118427.
Score: 0.006
-
ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules. J Clin Invest. 2023 12 05; 134(4).
Score: 0.006
-
Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis. Sci Transl Med. 2023 02 08; 15(682):eadc9653.
Score: 0.005
-
Individual-specific functional epigenomics reveals genetic determinants of adverse metabolic effects of glucocorticoids. Cell Metab. 2021 08 03; 33(8):1592-1609.e7.
Score: 0.005
-
Patient Adipose Stem Cell-Derived Adipocytes Reveal Genetic Variation that Predicts Antidiabetic Drug Response. Cell Stem Cell. 2019 02 07; 24(2):299-308.e6.
Score: 0.004
-
Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance. Cancer Res. 2015 Mar 15; 75(6):924-9.
Score: 0.003